¥1,438.50
2.34%
Tokyo, Sep 18, 11:18 am JST. Closed.
ISIN
JP3673600007
Symbol
8086

Nipro Corp Stock price

¥1,443.00
-145.50 9.16% 1M
-79.00 5.19% 6M
-34.00 2.30% YTD
-104.50 6.75% 1Y
+208.00 16.84% 3Y
+248.00 20.75% 5Y
+173.00 13.62% 10Y
+378.00 35.49% 20Y
Tokyo, Closing price Fri, Sep 18 2026
-30.00 2.04%
ISIN
JP3673600007
Symbol
8086

Is Nipro Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
¥238.8b
Enterprise Value
¥795.4b
Net debt
¥556.7b
Cash
¥104.9b
Shares outstanding
166.2m
Valuation (TTM | estimate)
P/E
19.0
P/S
0.4 | 0.3
EV/Sales
1.2 | 1.1
EV/FCF
-
P/B
0.8
Dividends
DPS
¥32.00
Yield 1Y | 5Y
2.2% | 2.1%
Growth 1Y | 5Y
10.3% | 3.5%
Payout 1Y | 3Y
39.5% | 48.9%
Increased
2 Years
Financials (TTM | estimate)
Revenue
¥668.9b | ¥716.0b
EBITDA
-
EBIT
¥38.1b
Net Income
¥14.1b
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
2.7% | 8.4%
EBITDA
-
EBIT
36.0%
Net Income
144.4%
Free Cash Flow
-
Margin
Gross
31.7%
EBITDA
-
EBIT
5.7%
Net
2.1%
Free Cash Flow
-
Financial Health
Equity Ratio
22.6%
Return on Equity
4.9%
ROCE
4.9%
ROIC
2.3%
Debt/Equity
2.3
More
EPS
¥77.6
FCF per Share
-
Short interest
-
Employees
39k
Rev per Employee
¥16.9m

Nipro Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Nipro Corp forecast:

5x Buy
56%
4x Hold
44%

Analyst Opinions

9 Analysts have issued a Nipro Corp forecast:

Buy
56%
Hold
44%

Financial data from Nipro Corp

Jun '26
+/-
%
668,863 668,863
3% 3%
100%
- Direct Costs 456,764 456,764
0% 0%
68%
212,099 212,099
9% 9%
32%
- Selling and Administrative Expenses 173,977 173,977
4% 4%
26%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 38,122 38,122
36% 36%
6%
Net Profit 14,072 14,072
144% 144%
2%

In millions JPY.

Don't miss a Thing! We will send you all news about Nipro Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. The company is headquartered in Settsu-Shi, Osaka-Fu and currently employs 39,168 full-time employees. The company has three segments. The Medical segment consists of the domestic business division and the international business division. The domestic business division sells medical devices related to injections and infusions, artificial organs, high-performance medicines, and dialysis. The international business division, centered on the head office, has medical device manufacturing and sales bases overseas for regional expansion, selling medical devices related to injections and infusions, artificial organs, and diabetes. The Pharmaceutical segment sells pharmaceuticals related to kit preparation containers on a contract basis from pharmaceutical companies. The Pharma Packaging segment sells medical glass products such as glass tubes and ampoules, thermos flasks, and kit preparation containers in Japan.

Head office Japan
Employees 39,168
Website www.nipro.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today